Published guidance, NICE advice and quality standards | Guidance

Showing 611 to 620 of 797

Sort by

Published guidance, NICE advice and quality standards
Title	Reference number	Published	Last updated
Abatacept, adalimumab, etanercept and tocilizumab for treating juvenile idiopathic arthritis	TA373	16 December 2015	16 December 2015
Erlotinib and gefitinib for treating non-small-cell lung cancer that has progressed after prior chemotherapy	TA374	16 December 2015	16 December 2015
Ombitasvir–paritaprevir–ritonavir with or without dasabuvir for treating chronic hepatitis C	TA365	25 November 2015	25 November 2015
Vortioxetine for treating major depressive episodes	TA367	25 November 2015	25 November 2015
Ledipasvir–sofosbuvir for treating chronic hepatitis C	TA363	25 November 2015	25 November 2015
Tolvaptan for treating autosomal dominant polycystic kidney disease	TA358	28 October 2015	28 October 2015
Idelalisib for treating chronic lymphocytic leukaemia	TA359	28 October 2015	28 October 2015
Paclitaxel as albumin-bound nanoparticles with carboplatin for untreated non-small-cell lung cancer (terminated appraisal)	TA362	28 October 2015	28 October 2015
Vedolizumab for treating moderately to severely active Crohn's disease after prior therapy	TA352	26 August 2015	26 August 2015
Bevacizumab for treating relapsed, platinum‑resistant epithelial ovarian, fallopian tube or primary peritoneal cancer (terminated appraisal)	TA353	26 August 2015	26 August 2015